Raymond James & Associates View Ray, Inc. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 14, 2023	BUY	$3.28 - $4.81 $4,592 - $6,733	1,400 Added 0.88%	161,275 $558,000
Q4 2022 Feb 08, 2023	SELL	$3.65 - $4.82 $3,650 - $4,820	-1,000 Reduced 0.62%	159,875 $716,000
Q3 2022 Oct 25, 2022	SELL	$2.66 - $3.97 $13,566 - $20,247	-5,100 Reduced 3.07%	160,875 $586,000
Q2 2022 Aug 12, 2022	BUY	$2.42 - $4.05 $24,926 - $41,715	10,300 Added 6.62%	165,975 $440,000
Q1 2022 May 11, 2022	BUY	$3.45 - $5.83 $6,210 - $10,494	1,800 Added 1.17%	155,675 $610,000
Q4 2021 Feb 08, 2022	SELL	$4.89 - $7.59 $129,477 - $200,968	-26,478 Reduced 14.68%	153,875 $848,000
Q3 2021 Nov 02, 2021	BUY	$5.18 - $7.41 $156,322 - $223,618	30,178 Added 20.1%	180,353 $1.3 Million
Q2 2021 Aug 11, 2021	BUY	$3.94 - $6.75 $6,501 - $11,137	1,650 Added 1.11%	150,175 $991,000
Q1 2021 May 14, 2021	BUY	$4.03 - $7.25 $93,899 - $168,925	23,300 Added 18.61%	148,525 $646,000
Q4 2020 Feb 12, 2021	SELL	$2.78 - $4.5 $1,806 - $2,925	-650 Reduced 0.52%	125,225 $478,000
Q3 2020 Nov 04, 2020	SELL	$2.12 - $3.53 $424 - $706	-200 Reduced 0.16%	125,875 $441,000
Q2 2020 Jul 28, 2020	SELL	$1.66 - $2.73 $11,537 - $18,973	-6,950 Reduced 5.22%	126,075 $282,000
Q1 2020 Apr 21, 2020	BUY	$1.35 - $4.05 $17,246 - $51,738	12,775 Added 10.62%	133,025 $333,000
Q4 2019 Feb 12, 2020	BUY	$2.3 - $4.6 $79,580 - $159,160	34,600 Added 40.4%	120,250 $507,000
Q3 2019 Nov 07, 2019	BUY	$2.9 - $9.56 $179,365 - $591,286	61,850 Added 259.87%	85,650 $248,000
Q2 2019 Aug 06, 2019	BUY	$6.7 - $9.13 $36,180 - $49,302	5,400 Added 29.35%	23,800 $210,000
Q1 2019 May 06, 2019	BUY	$5.7 - $8.73 $14,820 - $22,698	2,600 Added 16.46%	18,400 $136,000
Q4 2018 Feb 11, 2019	SELL	$5.04 - $10.28 $30,240 - $61,679	-6,000 Reduced 27.52%	15,800 $96,000
Q3 2018 Nov 14, 2018	SELL	$7.12 - $12.44 $215,736 - $376,932	-30,300 Reduced 58.16%	21,800 $204,000
Q2 2018 Aug 14, 2018	SELL	$6.21 - $8.21 $18,630 - $24,630	-3,000 Reduced 5.44%	52,100 $361,000
Q1 2018 May 14, 2018	SELL	$6.26 - $10.12 $683,279 - $1.1 Million	-109,150 Reduced 66.45%	55,100 $354,000
Q4 2017 Feb 14, 2018	SELL	$5.6 - $9.9 $195,720 - $346,005	-34,950 Reduced 17.55%	164,250 $1.52 Million
Q3 2017 Nov 13, 2017	BUY	$4.73 - $6.16 $18,210 - $23,716	3,850 Added 1.97%	199,200 $1.15 Million
Q2 2017 Aug 14, 2017	BUY	N/A	195,350	195,350 $1.26 Million

Others Institutions Holding VRAY

# of Institutions

Shares Held

645K

Call Options Held

50K

Put Options Held

30K

View Full List

About ViewRay, Inc.

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

More about VRAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account